ONCS
$3.82
Oncosec Medical
$.15
4.09%
ONCS
Earnings Whisper ®
N/A
4th Quarter July 2020
Consensus:  ($0.10)
Revenue:  $0.00 Mil
Monday
Oct 5
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when ONCS reports earnings?
Beat
Meet
Miss

Where is ONCS's stock price going from here?
Up
Flat
Down
Stock chart of ONCS
Analysts
Summary of analysts' recommendations for ONCS
Score
Grade
Pivots
Resistance
$4.19
$4.05
$3.93

$3.79

Support
$3.67
$3.53
$3.41
Tweet
Growth
Description
OncoSec Medical Incorporated is a biomedical company engaged in the designing, development and commercialization of therapeutic oncology products. It also develops novel OMS ElectroOncology therapies and OncoSec Medical System for the treatment of solid tumors. OncoSec Medical Incorporated is based in San Diego, California.
Peers
Myriad GeneticsImmunomedicsCareDxQuidelMeridian BioscienceSurModics